Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
History of invasive and interventional cardiology wikipedia , lookup
Heart failure wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Electrocardiography wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Coronary artery disease wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
P05 Connective tissue growth factor inhibits myocardial growth, stimulates fibrosis, but preserves myocardial function in chronic pressure overload M. Shakil Ahmed1, Thomas von Lueder1,2, Jørgen A. Gravning1, Thor Edvardsen1,2, Erik Øie1,2, Birthe Mikkelsen1, Otto A.Smiseth1,2, Håvard Attramadal1,2 1 Inst. for Surgical Research and of Cardiology, Rikshospitalet-Radiumhospitalet Medical Center and University of Oslo. 2 Dept. Background: Myocardial expression of connective tissue growth factor (CTGF) is dramatically induced in heart failure (HF) of diverse etiologies. However, the physiologic and pathophysiologic roles of myocardial CTGF remain unresolved. Methods and Results: To elucidate the actions of myocardial CTGF and its putative role in HF transgenic mice with cardiac-restricted overexpression of CTGF were generated. Transgenic CTGF (Tg-CTGF) mice had slightly lower cardiac mass than that of non-transgenic littermate controls (NLC) (heart weight/tibia length of 4 months old male Tg-CTGF vs. NLC; 58.9±2.7 vs. 68.1±1.2 mg/cm, p<0.05). Consistently, echocardiography revealed significantly smaller end-diastolic interventricular septum thickness in Tg-CTGF. Simultaneous LV pressure-volume analysis did not disclose significant alterations of contractility and cardiac output. Histochemical analysis of myocardial tissue revealed interstitial fibrosis in Tg-CTGF mice. Increased myocardial collagen was confirmed by quantitation of myocardial hydroxyproline contents by HPLC (1.10±0.03 vs.0.82±0.05 pmol/mg dry weight in TgCTGF vs. NLC mice; p<0.05). Consistently, increased myocardial procollagen--I and -III mRNA levels in Tg-CTGF vs. NLC hearts were found. Morover, increased expression of antihypertrophic TGF-2 and GDF-15 mRNA, and decreased expression of EGF mRNA in Tg-CTGF vs. NLC mice was detected. Tg-CTGF and NLC mice were subjected to pressure overload by abdominal aortic banding (AB) or sham-operation (SH). Four weeks after AB, significant elevations of cardiac mass were observed both in Tg-CTGF-AB and NLC-AB mice. However, cardiac hypertrophy was significantly diminished in Tg-CTGF-AB versus NLC-AB. Simultaneous PV-analysis provided evidence of cardiac dysfunction in NLC-AB mice, i.e. significantly increased LVEDD, LVEDP, and decreased stroke volume and cardiac output compared to NLC-SH mice. Strikingly, Tg-CTGF-AB revealed essentially preserved LV pressure-volume relations. Elevations of myocardial BNP mRNA expression were significantly attenuated in Tg-CTGF-AB compared to NLC-AB mice. Conclusion: Myocardial CTGF causes interstitial fibrosis, but no evidence of restrictive cardiac dysfunction, and preserves left ventricular function due to pressure overload.